Anti-™ED9 monoclonal antibody

Pre-made anti-™ED9 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ™ED9/™ED9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1952-Ab-1/ GM-Tg-hg-IP1952-Ab-2Anti-Human ™ED9 monoclonal antibodyHuman
GM-Tg-rg-IP1952-Ab-1/ GM-Tg-rg-IP1952-Ab-2Anti-Rat ™ED9 monoclonal antibodyRat
GM-Tg-mg-IP1952-Ab-1/ GM-Tg-mg-IP1952-Ab-2Anti-Mouse ™ED9 monoclonal antibodyMouse
GM-Tg-cynog-IP1952-Ab-1/ GM-Tg-cynog-IP1952-Ab-2Anti-Cynomolgus/ Rhesus macaque ™ED9 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1952-Ab-1/ GM-Tg-felg-IP1952-Ab-2Anti-Feline ™ED9 monoclonal antibodyFeline
GM-Tg-cang-IP1952-Ab-1/ GM-Tg-cang-IP1952-Ab-2Anti-Canine ™ED9 monoclonal antibodyCanine
GM-Tg-bovg-IP1952-Ab-1/ GM-Tg-bovg-IP1952-Ab-2Anti-Bovine ™ED9 monoclonal antibodyBovine
GM-Tg-equg-IP1952-Ab-1/ GM-Tg-equg-IP1952-Ab-2Anti-Equine ™ED9 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1952-Ab-1/ GM-Tg-hg-IP1952-Ab-2; GM-Tg-rg-IP1952-Ab-1/ GM-Tg-rg-IP1952-Ab-2;
GM-Tg-mg-IP1952-Ab-1/ GM-Tg-mg-IP1952-Ab-2; GM-Tg-cynog-IP1952-Ab-1/ GM-Tg-cynog-IP1952-Ab-2;
GM-Tg-felg-IP1952-Ab-1/ GM-Tg-felg-IP1952-Ab-2; GM-Tg-cang-IP1952-Ab-1/ GM-Tg-cang-IP1952-Ab-2;
GM-Tg-bovg-IP1952-Ab-1/ GM-Tg-bovg-IP1952-Ab-2; GM-Tg-equg-IP1952-Ab-1/ GM-Tg-equg-IP1952-Ab-2
Products NameAnti-™ED9 monoclonal antibody
Formatmab
Target Name™ED9
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-™ED9 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1952-Ag-1Recombinant multi-species ™ED9/ GMP25/ HSGP25L2G protein
    ORF Viral VectorpGMLP002649human ™ED9 Lentivirus plasmid
    ORF Viral VectorvGMLP002649human ™ED9 Lentivirus particle
    ORF Viral VectorpGMLPm002252mouse Tmed9 Lentivirus plasmid
    ORF Viral VectorvGMLPm002252mouse Tmed9 Lentivirus particle


    Target information

    Target IDGM-IP1952
    Target Name™ED9
    Gene ID54732,67511,361207,701114,481444,101088905,100068443
    Gene Symbol and Synonyms2400003B06Rik,GMP25,HSGP25L2G,p24a2,p24alpha2,p25,RGD1307627,™ED9
    Uniprot AccessionQ9BVK6,Q5I0E7
    Uniprot Entry Name™ED9_HUMAN,™ED9_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000184840
    Target ClassificationN/A

    The target: ™ED9, gene name: ™ED9, also named as GMP25, HSGP25L2G, p24a2, p24alpha2, p25. This gene is a member of a family of genes encoding transport proteins located in the endoplasmic reticulum and the Golgi. A similar gene in mouse is the target of microRNA miR-296, which is part of an imprinted cluster. [provided by RefSeq, Jul 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.